Literature DB >> 21556676

Absence of indigenous specific West Nile virus antibodies in Tyrolean blood donors.

S T Sonnleitner1, J Simeoni, E Schmutzhard, M Niedrig, F Ploner, H Schennach, M P Dierich, G Walder.   

Abstract

In the last several years, West Nile virus (WNV) was proven to be present especially in the neighboring countries of Austria, such as Italy, Hungary, and the Czech Republic, as well as in eastern parts of Austria, where it was detected in migratory and domestic birds. In summer 2010, infections with WNV were reported from Romania and northern Greece with about 150 diseased and increasingly fatal cases. We tested the sera of 1,607 blood donors from North Tyrol (Austria) and South Tyrol (Italy) for antibodies against WNV by using IgG enzyme-linked immunosorbent assay (ELISA). Initial results of the ELISA tests showed seroprevalence rates of 46.2% in North Tyrol and 0.5% in South Tyrol, which turned out to be false-positive cross-reactions with antibodies against tick-borne encephalitis virus (TBEV) by adjacent neutralization assays. These results indicate that seropositivity against WNV requires confirmation by neutralization assays, as cross-reactivity with TBEV is frequent and because, currently, WNV is not endemic in the study area.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21556676     DOI: 10.1007/s10096-011-1279-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Potential for New York mosquitoes to transmit West Nile virus.

Authors:  M J Turell; M O'Guinn; J Oliver
Journal:  Am J Trop Med Hyg       Date:  2000-03       Impact factor: 2.345

2.  Detection and molecular analysis of West Nile virus infections in birds of prey in the eastern part of Austria in 2008 and 2009.

Authors:  Eveline Wodak; Susanne Richter; Zoltán Bagó; Sandra Revilla-Fernández; Herbert Weissenböck; Norbert Nowotny; Petra Winter
Journal:  Vet Microbiol       Date:  2010-12-14       Impact factor: 3.293

Review 3.  West Nile virus in Europe: understanding the present to gauge the future.

Authors:  P Reiter
Journal:  Euro Surveill       Date:  2010-03-11

4.  Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation.

Authors:  M Niedrig; K Sonnenberg; K Steinhagen; J T Paweska
Journal:  J Virol Methods       Date:  2006-11-03       Impact factor: 2.014

5.  Factors affecting the geographic distribution of West Nile virus in Georgia, USA: 2002-2004.

Authors:  Samantha E J Gibbs; Michael C Wimberly; Marguerite Madden; Janna Masour; Michael J Yabsley; David E Stallknecht
Journal:  Vector Borne Zoonotic Dis       Date:  2006       Impact factor: 2.133

6.  Epidemiology of west nile in europe and in the mediterranean basin.

Authors:  Paolo Calistri; Armando Giovannini; Zdenek Hubalek; Aurelia Ionescu; Federica Monaco; Giovanni Savini; Rossella Lelli
Journal:  Open Virol J       Date:  2010-04-22

7.  West Nile virus range expansion into British Columbia.

Authors:  David Roth; Bonnie Henry; Sunny Mak; Mieke Fraser; Marsha Taylor; Min Li; Ken Cooper; Allen Furnell; Quantine Wong; Muhammad Morshed
Journal:  Emerg Infect Dis       Date:  2010-08       Impact factor: 6.883

8.  Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe.

Authors:  Tamás Bakonyi; Eva Ivanics; Károly Erdélyi; Krisztina Ursu; Emöke Ferenczi; Herbert Weissenböck; Norbert Nowotny
Journal:  Emerg Infect Dis       Date:  2006-04       Impact factor: 6.883

Review 9.  West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas.

Authors:  H G Zeller; I Schuffenecker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 5.103

10.  Novel flavivirus or new lineage of West Nile virus, central Europe.

Authors:  Tamás Bakonyi; Zdenek Hubálek; Ivo Rudolf; Norbert Nowotny
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.